-transparent.png){kind=logo}
Monkey pox virus was mechanically disrupted by low temperature and high pressure into soluble and insoluble fractions. Soluble fractions elicited virus-neutralizing antibodies (1:20 to 1:160) in rabbits, whereas the insoluble (in saline) fractions did not (less than 1:5). No infectious virus was detected after the disruption procedure. Rhesus monkeys immunized with the soluble fraction elicited virus-neutralizing (1:1,200), complement-fixing (1:16), and hemagglutinating-inhibiting (1:80 to 1:160) antibody titers and were completely protected against monkey pox virus-induced disease. This model of monkey pox virus subunit vaccine preparation may prove to be useful in developing an efficacious noninfectious vaccinia vaccine for use in high-risk individuals.
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1988,
Acta virologica,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1967,
Archiv fur die gesamte Virusforschung,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1971,
Voprosy virusologii,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
December 1984,
Uirusu,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
May 1973,
Biochimica et biophysica acta,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1981,
Acta veterinaria Academiae Scientiarum Hungaricae,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1964,
Voprosy virusologii,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
May 2023,
Open veterinary journal,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1986,
Voprosy virusologii,
R G Olsen, and
J R Blakeslee, and
L Mathes, and
J H Nakano
January 1967,
Antimicrobial agents and chemotherapy,
